Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype - 29/05/14

Abstract |
Background |
Autosomal recessive loss-of-function mutations in dedicator of cytokinesis 8 (DOCK8) cause a combined immunodeficiency characterized by atopy, recurrent infections, and cancer susceptibility. A genotype-phenotype explanation for the variable disease expression is lacking.
Objective |
We investigated whether reversions contributed to the variable disease expression.
Methods |
Patients followed at the National Institutes of Health's Clinical Center were studied. We performed detailed genetic analyses and intracellular flow cytometry to detect DOCK8 protein expression within lymphocyte subsets.
Results |
We identified 17 of 34 DOCK8-deficient patients who had germline mutations with variable degrees of reversion caused by somatic repair. Somatic repair of the DOCK8 mutations resulted from second-site mutation, original-site mutation, gene conversion, and intragenic crossover. Higher degrees of reversion were associated with recombination-mediated repair. DOCK8 expression was restored primarily within antigen-experienced T cells or natural killer cells but less so in naive T or B cells. Several patients exhibited multiple different repair events. Patients who had reversions were older and had less severe allergic disease, although infection susceptibility persisted. No patients were cured without hematopoietic cell transplantation.
Conclusions |
In patients with DOCK8 deficiency, only certain combinations of germline mutations supported secondary somatic repair. Those patients had an ameliorated disease course with longer survival but still had fatal complications or required hematopoietic cell transplantation. These observations support the concept that some DOCK8-immunodeficient patients have mutable mosaic genomes that can modulate disease phenotype over time.
Le texte complet de cet article est disponible en PDF.Key words : Dedicator of cytokinesis 8, reversion, somatic repair, recombination, gene conversion, intragenic single crossover, T cell, natural killer cell, allergy, immunodeficiency
Abbreviations used : DOCK8, HCT, NK, SNP, TCR
Plan
| Supported by the Intramural Research Program and the Vaccine Research Center of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. |
|
| Disclosure of potential conflict of interest: T. P. Atkinson has received consultancy fees from the American Board of Allergy & Immunology; has received consultancy fees from Best Doctors; and has received research support from the Kaul Pediatric Research Institute, Children's of Alabama, and the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID). A. R. Kumar has received research support from the NIH/National Heart, Lung, and Blood Institute. R. S. Geha has received research support from the NIAID (1R01AI100315-01A1). The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 133 - N° 6
P. 1667-1675 - juin 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
